|
⚲
|
| Keyboard |
| Ana Stancic | |
|---|---|
| Firm | |
| Address | c/o Immune Pharmaceuticals Inc 708 Third Avenue, Suite 210 New York, NY 10017 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Immune Pharmaceuticals Inc | 021-215479 | Director | 11.7 M of 11.7 M |
||
| Champions Oncology Inc | 021-191496 | Director | 9.3 M of 9.3 M |
||
| Champions Oncology Inc | 021-173340 | Director | 0.0 M of 0.0 M |
||
| Champions Oncology Inc | 021-158362 | Director | 9.4 M of 9.4 M |
||
| Champions Oncology Inc | 021-157992 | Director | 0.0 M of 0.0 M |
||
| KV Pharmaceutical Co /DE/ | 021-157753 | Director | 225.0 M of 225.0 M |
||
| KV Pharmaceutical Co /DE/ | 021-156249 | Director | 32.3 M of 32.3 M |
||
| KV Pharmaceutical Co /DE/ | 021-151410 | Director | 7.6 M of 7.6 M |
||
| Champions Biotechnology Inc | 021-149858 | Director | |||
| Champions Biotechnology Inc | 021-77185-6A | Director | 2.1 M of 10.0 M |
||